Biodexa Pharmaceuticals (BDRX) Receivables - Net (2013 - 2026)
Biodexa Pharmaceuticals (BDRX) recorded Receivables - Net of $3.94 million in the quarter ended Jun 30, 2026, down 34.3% from $6 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Receivables - Net (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals reported Receivables - Net of $4.99 million, down 40.5% from the prior year.
- Annual Receivables - Net has a five-year compound annual growth rate of 46.7% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Receivables - Net came in at $8.4 million in the year ended Dec 31, 2024 (+959.6%), $792,315 in the year ended Dec 31, 2023 (-36.4%), $1.25 million in the year ended Dec 31, 2022 (-12.5%) and $1.42 million in the year ended Dec 31, 2021 (+93.7%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Receivables - Net since the quarter ended Jun 30, 2024.
- On a year-over-year basis, Receivables - Net rose in two of the last four quarters, with growth averaging 259.7%.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 966.3% in the quarter ended Dec 31, 2024, against a decline of 40.3% in the quarter ended Dec 31, 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Biodexa Pharmaceuticals | 3,915.67 | -23.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.89 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Dec 31, 2023 | 811,154.93 |
| Jun 30, 2023 | 1.14 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Jun 30, 2021 | 1.94 Mn |
| Dec 31, 2020 | 779,673.93 |
| Jun 30, 2020 | 4.52 Mn |
| Dec 31, 2019 | 1.30 Mn |
| Jun 30, 2019 | 3.25 Mn |
| Dec 31, 2018 | 1.68 Mn |
| Jun 30, 2018 | 940,102.70 |
| Dec 31, 2017 | 4.36 Mn |
| Jun 30, 2017 | 3.36 Mn |
| Dec 31, 2016 | 3.00 Mn |
| Jun 30, 2016 | 2.02 Mn |
API Access
Biodexa Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();